Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SHS
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
148M
-
Shares change
-
+5.28M
-
Total reported value, excl. options
-
$2.44B
-
Value change
-
+$99.1M
-
Put/Call ratio
-
0.45
-
Number of buys
-
103
-
Number of sells
-
-90
-
Price
-
$16.56
Significant Holders of HORIZON PHARMA PLC - SHS (HZNP) as of Q2 2018
255 filings reported holding HZNP - HORIZON PHARMA PLC - SHS as of Q2 2018.
HORIZON PHARMA PLC - SHS (HZNP) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 148M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (14.3M shares), BlackRock Inc. (13.5M shares), SCOPIA CAPITAL MANAGEMENT LP (11.9M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (9.94M shares), PAULSON & CO. INC. (7.67M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6.61M shares), venBio Select Advisor LLC (5.59M shares), DIMENSIONAL FUND ADVISORS LP (5.42M shares), JPMORGAN CHASE & CO (5.4M shares), and RENAISSANCE TECHNOLOGIES LLC (5.01M shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.